SCHEMBL20429324

SCHEMBL20429324

CCc1cncc2ccc(C)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 6/20 0.43
MAPT P10636 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
ELANE P08246 2/20 0.39
CYP1A2 P05177 4/20 0.38
CYP2A6 P11509 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
ACHE P22303 1/20 0.35
IKBKB O14920 1/20 0.35
JAK2 O60674 1/20 0.35
ROCK2 O75116 1/20 0.35
JAK1 P23458 1/20 0.35
TYK2 P29597 1/20 0.35
JAK3 P52333 1/20 0.35
ROCK1 Q13464 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 2/20 0.35
KMT2A Q03164 2/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21845690 0.86 PDE10A (0.41) PDE10AMAPTELANECYP1A2CYP2A6
SCHEMBL3052255 0.81 EGFR (0.42) PDE10AMAPTACHEIKBKBJAK2
SCHEMBL21845759 0.80 PDE10A (0.38) PDE10AELANECYP1A2CYP2A6ACHE
SCHEMBL1705948 0.80 ESR1 (0.46) PDE10AIKBKBJAK2ROCK2JAK1
SCHEMBL1705752 0.77 PDE10A (0.55) PDE10ACYP1A2
SCHEMBL8404562 0.76 CYP1A2 (0.52) MAPTCYP1A2CYP2A6SMN1; SMN2HSD17B10
SCHEMBL873335 0.75 CYP11B1 (0.47) PDE10ACYP1A2HSD17B10ALDH1A1
SCHEMBL19383227 0.74 PDE10A (0.48) PDE10ACYP1A2CYP2A6
SCHEMBL19705388 0.73 CYP1A2 (0.41) PDE10AMAPTELANECYP1A2CYP2A6
SCHEMBL12114723 0.73 TRPA1 (0.46) MAPTCYP1A2CYP2A6SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020056345-A1 ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS AERIE PHARMACEUTICALS, INC. (US) 2020-03-19 WO disclosed
EP-3354643-A1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2018-08-01 EP disclosed